Page 1 | Search Results | Molecular Cancer Therapeutics | American Association for Cancer Research

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Combination Therapy of Avutometinib and MRTX1133 Synergistically Suppresses Cell Growth by Inducing Apoptosis in KRAS^G12D-Mutated Pancreatic Cancer

Ema Toyokuni, Mano Horinaka, Emi Nishimoto, Akihiro Yoshimura, Michiaki Fukui, Toshiyuki Sakai

Mol Cancer Ther OF1–OF9.

https://doi.org/10.1158/1535-7163.MCT-24-0831

Published: 10 June 2025

View article titled, Combination Therapy of Avutometinib and MRTX1133 Synergistically Suppresses Cell Growth by Inducing Apoptosis in KRASG12D-Mutated Pancreatic Cancer

Includes: Supplementary data

Journal Articles

Effects of Combined Therapeutic Targeting of AXL and ATR on Pleural Mesothelioma Cells

Soichi Hirai, Tadaaki Yamada, Yuki Katayama, Masaki Ishida, Hayato Kawachi, Yohei Matsui, Ryota Nakamura, Kenji Morimoto, Mano Horinaka, Toshiyuki Sakai, Yoshitaka Sekido, Shinsaku Tokuda, Koichi Takayama

Mol Cancer Ther (2024) 23 (2): 212–222.

https://doi.org/10.1158/1535-7163.MCT-23-0138

Published: 01 February 2024

View article titled, Effects of Combined Therapeutic Targeting of AXL and ATR on Pleural Mesothelioma Cells

Includes: Supplementary data

Journal Articles

A Histone Deacetylase Inhibitor, OBP-801, and Celecoxib Synergistically Inhibit the Cell Growth with Apoptosis via a DR5-Dependent Pathway in Bladder Cancer Cells

Seijiro Toriyama, Mano Horinaka, Shusuke Yasuda, Tomoyuki Taniguchi, Yuichi Aono, Toshiya Takamura, Yukako Morioka, Tsuneharu Miki, Osamu Ukimura, Toshiyuki Sakai

Mol Cancer Ther (2016) 15 (9): 2066–2075.

https://doi.org/10.1158/1535-7163.MCT-16-0010

Published: 01 September 2016

View article titled, A Histone Deacetylase Inhibitor, OBP-801, and Celecoxib Synergistically Inhibit the Cell Growth with Apoptosis via a DR5-Dependent Pathway in Bladder Cancer Cells

Includes: Supplementary data

Journal Articles

Targeting the Glyoxalase Pathway Enhances TRAIL Efficacy in Cancer Cells by Downregulating the Expression of Antiapoptotic Molecules

Hiroya Taniguchi, Mano Horinaka, Tatsushi Yoshida, Kimihiro Yano, Ahmed E. Goda, Shusuke Yasuda, Miki Wakada, Toshiyuki Sakai

Mol Cancer Ther (2012) 11 (10): 2294–2300.

https://doi.org/10.1158/1535-7163.MCT-12-0031

Published: 09 October 2012

View article titled, Targeting the Glyoxalase Pathway Enhances TRAIL Efficacy in Cancer Cells by Downregulating the Expression of Antiapoptotic Molecules

Includes: Supplementary data

Journal Articles

15-Deoxy-Δ^12,14-prostaglandin J₂ induces death receptor 5 expression through mRNA stabilization independently of PPARγ and potentiates TRAIL-induced apoptosis

Susumu Nakata, Tatsushi Yoshida, Takumi Shiraishi, Mano Horinaka, Junji Kouhara, Miki Wakada, Toshiyuki Sakai

Mol Cancer Ther (2006) 5 (7): 1827–1835.

https://doi.org/10.1158/1535-7163.MCT-06-0023

Published: 04 August 2006

View article titled, 15-Deoxy-Δ12,14-prostaglandin J2 induces death receptor 5 expression through mRNA stabilization independently of PPARγ and potentiates TRAIL-induced apoptosis

Journal Articles

The dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor–related apoptosis-inducing ligand

Mano Horinaka, Tatsushi Yoshida, Takumi Shiraishi, Susumu Nakata, Miki Wakada, Toshiyuki Sakai

Mol Cancer Ther (2006) 5 (4): 945–951.

https://doi.org/10.1158/1535-7163.MCT-05-0431

Published: 28 April 2006

View article titled, The dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor–related apoptosis-inducing ligand

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Combination Therapy of Avutometinib and MRTX1133 Synergistically Suppresses Cell Growth by Inducing Apoptosis in KRAS^G12D-Mutated Pancreatic Cancer

Effects of Combined Therapeutic Targeting of AXL and ATR on Pleural Mesothelioma Cells

A Histone Deacetylase Inhibitor, OBP-801, and Celecoxib Synergistically Inhibit the Cell Growth with Apoptosis via a DR5-Dependent Pathway in Bladder Cancer Cells

Targeting the Glyoxalase Pathway Enhances TRAIL Efficacy in Cancer Cells by Downregulating the Expression of Antiapoptotic Molecules

15-Deoxy-Δ^12,14-prostaglandin J₂ induces death receptor 5 expression through mRNA stabilization independently of PPARγ and potentiates TRAIL-induced apoptosis

The dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor–related apoptosis-inducing ligand

Email alerts

AACR Journals

Resources

AACR Journals
on Social Media

Update search

Combination Therapy of Avutometinib and MRTX1133 Synergistically Suppresses Cell Growth by Inducing Apoptosis in KRASG12D-Mutated Pancreatic Cancer

Effects of Combined Therapeutic Targeting of AXL and ATR on Pleural Mesothelioma Cells

A Histone Deacetylase Inhibitor, OBP-801, and Celecoxib Synergistically Inhibit the Cell Growth with Apoptosis via a DR5-Dependent Pathway in Bladder Cancer Cells

Targeting the Glyoxalase Pathway Enhances TRAIL Efficacy in Cancer Cells by Downregulating the Expression of Antiapoptotic Molecules

15-Deoxy-Δ12,14-prostaglandin J2 induces death receptor 5 expression through mRNA stabilization independently of PPARγ and potentiates TRAIL-induced apoptosis

The dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor–related apoptosis-inducing ligand

Email alerts

AACR Journals

Resources

AACR Journals on Social Media

This Feature Is Available To Subscribers Only

Combination Therapy of Avutometinib and MRTX1133 Synergistically Suppresses Cell Growth by Inducing Apoptosis in KRAS^G12D-Mutated Pancreatic Cancer

15-Deoxy-Δ^12,14-prostaglandin J₂ induces death receptor 5 expression through mRNA stabilization independently of PPARγ and potentiates TRAIL-induced apoptosis

AACR Journals
on Social Media